Jul 7, 2026 07:18AM
Jun 26, 2026 10:02AM
Jun 26, 2026 10:02AM
Jul 18, 2025 01:43PM
Jul 14, 2025 06:58AM
Jul 3, 2025 10:00AM
Jul 1, 2025 10:00AM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
Jun 28, 2025 10:00AM
Jun 28, 2025 10:00AM
Jun 26, 2025 02:13AM
Jun 24, 2025 12:29PM
Jun 24, 2025 10:44AM
Jun 24, 2025 09:01AM
Jun 24, 2025 09:00AM Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy
Jun 23, 2025 06:43AM
Jun 18, 2025 12:30PM
Jun 16, 2025 06:39AM
Jun 15, 2025 10:00AM
Jun 13, 2025 11:28AM
Jun 11, 2025 09:25AM
Jun 11, 2025 09:25AM Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program
Jun 10, 2025 09:00AM
Jun 6, 2025 12:12PM
Jun 2, 2025 01:55PM
May 28, 2025 09:00AM
May 22, 2025 09:00AM
May 18, 2025 10:00AM
May 13, 2025 04:05PM Capricor Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 13, 2025 12:03PM
May 9, 2025 10:53AM
May 5, 2025 08:06AM
May 5, 2025 08:00AM
Mar 5, 2025 06:48AM
Mar 4, 2025 07:02AM
Mar 4, 2025 07:00AM Capricor Therapeutics Announces FDA Acceptance and Priority Review of its Biologics License Application for Deramiocel to Treat Duchenne Muscular Dystrophy

15,734 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All